Annals of hepatology

Keyphrases

Publications

2023

Eric David Ornos, Karl Jeffrey Murillo, Janus P Ong
Liver diseases: Perspective from the Philippines. Annals of hepatology (2023)
Mingjing Jiao, Jiachao Wang, Wenpeng Liu, Xin Zhao, Yanjun Qin, Chunhuan Zhang, Hongzhu Yin, Caiyan Zhao
VX-765 inhibits pyroptosis and reduces inflammation to prevent acute liver failure by upregulating PPARα expression. Annals of hepatology (2023)
Lindsay A Sobotka, Ayushi Jain, Jing Peng, Kenneth D Allen, Chelsey J McShane, Mitchell L Ramsey, Michael R Wellner, Robert B Kirkpatrick
Patients with Alcohol-Related Liver Disease Hospitalized During the COVID-19 Pandemic Experienced Worse Outcomes. Annals of hepatology (2023)
Sven Pischke, Anita Shiprov, Ulrike Peters, Julian Schulze Zur Wiesch, Johannes Kluwe, Tim Westphal, Frank Fischer, Maria Mader, Thorben Fründt, Karoline Horvatits, Thomas Horvatits, Ghazal Aarabi, Thomas Beikler
High prevalence of periodontal disease in patients with NASH- possible association of poor dental health with NASH severity. Annals of hepatology (2023)
Jie Chen, Sha Luo, Feng Tang, Ming Han, Jie Zheng, Mingming Deng, Gang Luo
Development and validation of a practical prognostic nomogram for evaluating inpatient mortality of cirrhotic patients with acute variceal hemorrhage. Annals of hepatology (2023)
Marcos A Thompson, Francisca Martinez-Barbini, Manuel Mendizabal
SARS-CoV-2 vaccination in liver transplant recipients: We still haven't found what we are looking for. Annals of hepatology (2023)
Marcos A Thompson, Francisca Martinez-Barbini, Manuel Mendizabal
SARS-CoV-2 vaccination in liver transplant recipients: We still haven´t found what we are looking for. Annals of hepatology (2023)
Hirsh D Trivedi, Qua Tran, Zachary Fricker, Michael P Curry, Jonathan X Li, Michelle Lai
Type 2 diabetes complications are associated with liver fibrosis independent of hemoglobin A1c. Annals of hepatology (2023)
Deanna D Hill, Jennifer R Kramer, Kassie R Chaffin, T Christopher Mast, Michael Robertson, Fasiha Kanwal, Barbara A Haber
Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance. Annals of hepatology (2023)
María Carolina Martínez-Bohorquez, Martha Carnalla, Norberto Chávez-Tapia, Tonatiuh Barrientos-Gutiérrez
Hepatitis C mortality trends in Mexico from 2001 to 2017. Annals of hepatology (2023)
Sven Pischke, Anita Shiprov, Ulrike Peters, Julian Schulze Zur Wiesch, Johannes Kluwe, Tim Westphal, Frank Fischer, Maria Mader, Thorben Fründt, Karoline Horvatits, Thomas Horvatits, Ghazal Aarabi, Thomas Beikler
High prevalence of periodontal disease in patients with NASH- possible association of poor dental health with NASH severity. Annals of hepatology (2023)
Lindsay A Sobotka, Ayushi Jain, Jing Peng, Kenneth D Allen, Chelsey J McShane, Mitchell L Ramsey, Michael R Wellner, Robert B Kirkpatrick
Patients with Alcohol-Related Liver Disease Hospitalized During the COVID-19 Pandemic Experienced Worse Outcomes. Annals of hepatology (2023)
Mahak Chauhan, Talan Zhang, Paul J Thuluvath
Combined effects of hyponatremia and hepatic encephalopathy on inpatient mortality. Annals of hepatology (2023)
Zhao Yang, Jianwei Liu, Feng Xue, Lei Zhang, Hui Xue, Yeye Wu, Shilei Bai, Furong Du, Xiaoxuan Wang, Wanglong Deng, Chao Song, Kui Wang
Genomic landscape of Chinese patients with hepatocellular carcinoma using next-generation sequencing and its association with the prognosis. Annals of hepatology (2023)
Itamar Krispin, Mahmud Mahamid, Eran Goldin, Bashar Fteiha
Elevated lactate/albumin ratio as a novel predictor of in-hospital mortality in hospitalized cirrhotics. Annals of hepatology (2023)

volume 28, number 1, 2023

Norberto Chávez-Tapia
Change of courier for Annals of Hepatology. Annals of hepatology 28 (1) (2023)
Norberto Chávez-Tapia
Change of courier for Annals of Hepatology. Annals of hepatology 28 (1) (2023)

volume 28, number 2, 2023

Eloy Ruiz, Ramiro Fernández, Francisco Berrospi, Sandro Casavilca-Zambrano, Juan Contreras-Mancilla, Juan Pablo Cerapio, Pascal Pineau, Stéphane Bertani
On the risk of further excluding outcast patient populations in South America. Annals of hepatology 28 (2) (2023)
Sven Pischke, Anita Shiprov, Ulrike Peters, Julian Schulze Zur Wiesch, Johannes Kluwe, Tim Westphal, Frank Fischer, Maria Mader, Thorben Fründt, Karoline Horvatits, Thomas Horvatits, Ghazal Aarabi, Thomas Beikler
High prevalence of periodontal disease in patients with NASH- possible association of poor dental health with NASH severity. Annals of hepatology 28 (2) (2023)
Deanna D Hill, Jennifer R Kramer, Kassie R Chaffin, T Christopher Mast, Michael N Robertson, Fasiha Kanwal, Barbara A Haber
Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance. Annals of hepatology 28 (2) (2023)
Zhao Yang, Jianwei Liu, Feng Xue, Lei Zhang, Hui Xue, Yeye Wu, Shilei Bai, Furong Du, Xiaoxuan Wang, Wanglong Deng, Chao Song, Kui Wang
Genomic landscape of Chinese patients with hepatocellular carcinoma using next-generation sequencing and its association with the prognosis. Annals of hepatology 28 (2) (2023)
Parul D Agarwal, Michael R Lucey, Adnan Said, Jeremy Kratz
Immunotherapy for HCC: limitations in patients with NASH. Annals of hepatology 28 (2) (2023)
Deanna D Hill, Jennifer R Kramer, Kassie R Chaffin, T Christopher Mast, Michael N Robertson, Fasiha Kanwal, Barbara A Haber
Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance. Annals of hepatology 28 (2) (2023)
Sven Pischke, Anita Shiprov, Ulrike Peters, Julian Schulze Zur Wiesch, Johannes Kluwe, Tim Westphal, Frank Fischer, Maria Mader, Thorben Fründt, Karoline Horvatits, Thomas Horvatits, Ghazal Aarabi, Thomas Beikler
High prevalence of periodontal disease in patients with NASH- possible association of poor dental health with NASH severity. Annals of hepatology 28 (2) (2023)
Deanna D Hill, Jennifer R Kramer, Kassie R Chaffin, T Christopher Mast, Michael N Robertson, Fasiha Kanwal, Barbara A Haber
Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance. Annals of hepatology 28 (2) (2023)
Deanna D Hill, Jennifer R Kramer, Kassie R Chaffin, T Christopher Mast, Michael N Robertson, Fasiha Kanwal, Barbara A Haber
Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance. Annals of hepatology 28 (2) (2023)
Zhao Yang, Jianwei Liu, Feng Xue, Lei Zhang, Hui Xue, Yeye Wu, Shilei Bai, Furong Du, Xiaoxuan Wang, Wanglong Deng, Chao Song, Kui Wang
Genomic landscape of Chinese patients with hepatocellular carcinoma using next-generation sequencing and its association with the prognosis. Annals of hepatology 28 (2) (2023)
Zhao Yang, Jianwei Liu, Feng Xue, Lei Zhang, Hui Xue, Yeye Wu, Shilei Bai, Furong Du, Xiaoxuan Wang, Wanglong Deng, Chao Song, Kui Wang
Genomic landscape of Chinese patients with hepatocellular carcinoma using next-generation sequencing and its association with the prognosis. Annals of hepatology 28 (2) (2023)
Zhao Yang, Jianwei Liu, Feng Xue, Lei Zhang, Hui Xue, Yeye Wu, Shilei Bai, Furong Du, Xiaoxuan Wang, Wanglong Deng, Chao Song, Kui Wang
Genomic landscape of Chinese patients with hepatocellular carcinoma using next-generation sequencing and its association with the prognosis. Annals of hepatology 28 (2) (2023)
Yasuhiro Nakano, Yoshikazu Johmura
Targeting cellular senescence as a therapeutic approach in non-alcoholic steatohepatitis. Annals of hepatology 28 (2) (2023)
Andres Gomez-Aldana, Diego Rosselli
Hepatocellular carcinoma in Colombia 2017 - 2021. Annals of hepatology 28 (2) (2023)
Zhao Yang, Jianwei Liu, Feng Xue, Lei Zhang, Hui Xue, Yeye Wu, Shilei Bai, Furong Du, Xiaoxuan Wang, Wanglong Deng, Chao Song, Kui Wang
Genomic landscape of Chinese patients with hepatocellular carcinoma using next-generation sequencing and its association with the prognosis. Annals of hepatology 28 (2) (2023)
Jose D Debes, Chimaobi Anugwom, Marina Farah, Javier Diaz-Ferrer
Response to "On the risk of further excluding outcast patient populations in South America". Annals of hepatology 28 (2) (2023)
Sven Pischke, Anita Shiprov, Ulrike Peters, Julian Schulze Zur Wiesch, Johannes Kluwe, Tim Westphal, Frank Fischer, Maria Mader, Thorben Fründt, Karoline Horvatits, Thomas Horvatits, Ghazal Aarabi, Thomas Beikler
High prevalence of periodontal disease in patients with NASH- possible association of poor dental health with NASH severity. Annals of hepatology 28 (2) (2023)
Zhao Yang, Jianwei Liu, Feng Xue, Lei Zhang, Hui Xue, Yeye Wu, Shilei Bai, Furong Du, Xiaoxuan Wang, Wanglong Deng, Chao Song, Kui Wang
Genomic landscape of Chinese patients with hepatocellular carcinoma using next-generation sequencing and its association with the prognosis. Annals of hepatology 28 (2) (2023)

volume 28, number 3, 2023

Itamar Krispin, Mahmud Mahamid, Eran Goldin, Bashar Fteiha
Elevated lactate/albumin ratio as a novel predictor of in-hospital mortality in hospitalized cirrhotics. Annals of hepatology 28 (3) (2023)
Mariana Verdelho Machado
Hepatocellular carcinoma screening in NAFLD: The paradox of nearly half the cases arising in non-cirrhotic low risk patients. Annals of hepatology 28 (3) (2023)
Mariana Verdelho Machado
Hepatocellular carcinoma screening in NAFLD: The paradox of nearly half the cases arising in non-cirrhotic low risk patients. Annals of hepatology 28 (3) (2023)

volume 28, number 4, 2023

Federico Piñero, Margarita Anders, Carla Bermudez, Ezequiel Demirdjian, Adriana Varón, Ana Palazzo, Jorge Rodriguez, Oscar Beltrán, Leonardo Gomes da Fonseca, Ezequiel Ridruejo, Pablo Caballini, Norberto Tamagnone, Virginia Reggiardo, Hugo Cheinquer, Alexandre Araujo, Diego Arufe, Juan Ignacio Marín, Natalia Ratusnu, Estela Manero, Daniela Perez, Marina Villa, Federico Orozco, Dolores Murga, Sebastián Marciano, Fernando Bessone, Marcelo Silva, Manuel Mendizabal
Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC. Annals of hepatology 28 (4) (2023)
James M Paik, Katherine E Eberly, Khaled Kabbara, Michael Harring, Youssef Younossi, Linda Henry, Manisha Verma, Zobair M Younossi
Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.). Annals of hepatology 28 (4) (2023)
Zhenjing Wang, Nai Liu, Caixia Guo
Comment on "Type 2 Diabetes Complications are Associated with Liver Fibrosis Independent of Hemoglobin A1c". Annals of hepatology 28 (4) (2023)
Luis Antonio Manzo-Francisco, Jorge Aquino-Matus, Dèsirée Vidaña-Pérez, Misael Uribe, Norberto Chavez-Tapia
Systematic review and meta-analysis: Transient elastography compared to liver biopsy for staging of liver fibrosis in primary biliary cholangitis. Annals of hepatology 28 (4) (2023)
Luis Antonio Manzo-Francisco, Jorge Aquino-Matus, Dèsirée Vidaña-Pérez, Misael Uribe, Norberto Chavez-Tapia
Systematic review and meta-analysis: Transient elastography compared to liver biopsy for staging of liver fibrosis in primary biliary cholangitis. Annals of hepatology 28 (4) (2023)
Ke Su, Qiuni Shen, Jian Tong, Tao Gu, Ke Xu, Han Li, Hao Chi, Yanlin Liu, Xueting Li, Lianbin Wen, Yanqiong Song, Qulian Guo, Jiali Chen, Zhenying Wu, Yi Jiang, Kun He, Lu Guo, Yunwei Han
Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: A large, multicenter study. Annals of hepatology 28 (4) (2023)
Juan Ignacio Marín, Margarita Anders, Aline Chagas, Josemaría Menéndez, Oscar Beltran, Enrique Carrera Estupiñan, Javier Diaz Ferrer, Angelo A Mattos, Federico Piñero, null null
The leading and key role of hepatologists in the multidisciplinary management of patients with hepatocellular carcinoma. Annals of hepatology 28 (4) (2023)
Federico Guillermo Villamil, Manuel Barbero, Nancy Elena Massenzio, Sandra Mónica Giani, Shigeru Kozima, Fernando Mario Cairo, Rodrigo Agustín Belloni, Javier Mariani, Mercedes Rodriguez Gazari, Paola Evangelina Coisson, Sonia Carolina Gallardo, Paula Andrea Cocco, Claudia Mabel Riboldi, Patricia Eugenia Gallardo
Prevalence of non-alcoholic fatty liver disease and liver fibrosis in a general population cohort from Argentina. Annals of hepatology 28 (4) (2023)
Amedeo Lonardo
Shutting those revolving doors. Annals of hepatology 28 (4) (2023)
Hirsh D Trivedi, Michelle Lai
Reply to: Type 2 Diabetes Complications are Associated with Liver Fibrosis Independent of Hemoglobin A1c. Annals of hepatology 28 (4) (2023)
Amedeo Lonardo
Shutting those revolving doors. Annals of hepatology 28 (4) (2023)
Michelle Harriz Braga, Guilherme Grossi Lopes Cançado, Paulo Lisboa Bittencourt, Cláudia Alves Couto, Laura Vilar Guedes, André Mourão Costa Lima, Maria Lucia Gomes Ferraz, Cristiane Alves Villela-Nogueira, Mateus Jorge Nardelli, Luciana Costa Faria, Nathalia Mota de Faria Gomes, Elze Maria Gomes Oliveira, Vivian Rotman, Maria Beatriz Oliveira, Simone Muniz Carvalho Fernandes da Cunha, Marlone Cunha-Silva, Liliana Sampaio Costa Mendes, Claudia Alexandra Pontes Ivantes, Liana Codes, Valéria Ferreira de Almeida E Borges, Fabio Heleno de Lima Pace, Mario Guimarães Pessoa, Izabelle Venturini Signorelli, Gabriela Perdomo Coral, João Galizzi Filho, Aline Lopes Chagas, Debora Raquel Benedita Terrabuio, Eduardo Luiz Rachid Cançado, null null
Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome. Annals of hepatology 28 (4) (2023)